Cyclofenil versus Placebo in Progressive Systemic Sclerosis
- 12 January 1981
- journal article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 210 (1-6), 419-428
- https://doi.org/10.1111/j.0954-6820.1981.tb09842.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Synthesis of Collagen and Sulfated Glycosaminoglycans by Normal and Scleroderma Fibroblasts in Culture, with and without Addition of CyclofenilActa Medica Scandinavica, 1981
- Improvement of Lung Function in a Scleroderma Patient Treated for 12 Months with CyclofenilUpsala Journal of Medical Sciences, 1980
- HDL‐Increasing Effect of CyclofenilActa Medica Scandinavica, 1980
- Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine.Annals Of The Rheumatic Diseases, 1979
- Treatment of Progressive Systemic Sclerosis (Scleroderma, PSS) with a New Drug Influencing Connective TissueActa Medica Scandinavica, 1977
- TREATMENT OF PROGRESSIVE SYSTEMIC SCLEROSIS WITH A SYNTHETIC WEAK ESTROGEN: CYCLOFENIL (SEXOVID®)Acta Medica Scandinavica, 1974
- Gestagenbehandlung der SklerodermieDeutsche Medizinische Wochenschrift (1946), 1972
- A Simple Method for the Determination of Glomerular Filtration RateScandinavian Journal of Clinical and Laboratory Investigation, 1972
- Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment.Annals Of The Rheumatic Diseases, 1970
- A Method for Determination of Pulmonary Elastic Recoil and Resistance at a Regulated Flow RateScandinavian Journal of Clinical and Laboratory Investigation, 1969